+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)



Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)



Plos Medicine 10(9): E1001510



Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to explore the impact of LP on AIDS and mortality. LP was defined in Collaboration of Observational HIV Epidemiological Research Europe (COHERE) as HIV diagnosis with a CD4 count <350/mm(3) or an AIDS diagnosis within 6 months of HIV diagnosis among persons presenting for care between 1 January 2000 and 30 June 2011. Logistic regression was used to identify factors associated with LP and Poisson regression to explore the impact on AIDS/death. 84,524 individuals from 23 cohorts in 35 countries contributed data; 45,488 were LP (53.8%). LP was highest in heterosexual males (66.1%), Southern European countries (57.0%), and persons originating from Africa (65.1%). LP decreased from 57.3% in 2000 to 51.7% in 2010/2011 (adjusted odds ratio [aOR] 0.96; 95% CI 0.95-0.97). LP decreased over time in both Central and Northern Europe among homosexual men, and male and female heterosexuals, but increased over time for female heterosexuals and male intravenous drug users (IDUs) from Southern Europe and in male and female IDUs from Eastern Europe. 8,187 AIDS/deaths occurred during 327,003 person-years of follow-up. In the first year after HIV diagnosis, LP was associated with over a 13-fold increased incidence of AIDS/death in Southern Europe (adjusted incidence rate ratio [aIRR] 13.02; 95% CI 8.19-20.70) and over a 6-fold increased rate in Eastern Europe (aIRR 6.64; 95% CI 3.55-12.43). LP has decreased over time across Europe, but remains a significant issue in the region in all HIV exposure groups. LP increased in male IDUs and female heterosexuals from Southern Europe and IDUs in Eastern Europe. LP was associated with an increased rate of AIDS/deaths, particularly in the first year after HIV diagnosis, with significant variation across Europe. Earlier and more widespread testing, timely referrals after testing positive, and improved retention in care strategies are required to further reduce the incidence of LP.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579257

Download citation: RISBibTeXText

PMID: 24137103

DOI: 10.1371/journal.pmed.1001510


Related references

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveillance 20(47), 2016

Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. International Journal of Epidemiology 46(3): 797-797n, 2016

Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe. EUROSTROKE: A collaborative study among research centres in Europe: rationale and design. Neuroepidemiology 15(6): 291-300, 1996

Airway management in paediatric anaesthesia in Europe-insights from APRICOT (Anaesthesia Practice In Children Observational Trial): a prospective multicentre observational study in 261 hospitals in Europe. British Journal of Anaesthesia 121(1): 66-75, 2018

Risk factors for suicidality in Europe: results from the ESEMED study. Journal of Affective Disorders 101(1-3): 27-34, 2006

Effectiveness of antipsychotic treatments for patients from the Central Eastern Europe region participating in the 3-year intercontinental schizophrenia outpatient health outcomes observational study 6-Month results. European Neuropsychopharmacology 13(Supplement 4): S307-S308, 2003

Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. Aids and Behavior 17 Suppl 2: S203-S211, 2014

Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) study. Bmc Public Health 13: 362, 2013

Fruit and vegetable consumption and mortality in Eastern Europe: Longitudinal results from the Health, Alcohol and Psychosocial Factors in Eastern Europe study. European Journal of Preventive Cardiology 23(5): 493-501, 2016

Risk factors for late defecation and its association with the outcomes of critically ill patients: a retrospective observational study. Journal of Intensive Care 4: 33, 2016

Comments to: Risk factors for late defecation and its association with the outcomes of critically ill patients: a retrospective observational study. Journal of Intensive Care 4: 46-46, 2016

Observational Epidemiological Study To Assess Cardiovascular Risk Factors in Heart Transplant Recipients in Spain (CTC Study): Preliminary Results at 18 Months Post-Transplantation. Journal of Heart and Lung Transplantation 32(4): S205-S206, 2013

Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. European Psychiatry 23(1): 66-73, 2008

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. European Heart Journal 29(14): 1761-1771, 2008

Risk factors for cardiovascular diseases in patients starting dialysis in northern and southern Europe Results from the MPO study. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 359A, 2001